drugset

drugset / Trial / NCT00158379

Taxol Carboplatin and Erythropoetin

NCT00158379 ↗

Phase 2 Completed 105 enrolled North Eastern German Society of Gynaecological Oncology

NaSingle-groupOpen-labelTreatment

Summary

Time to progression (physical examination and radiologic imaging

Timeline

Start: 2003-07
Primary completion: 2008-04
Completion: 2008-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Paclitaxel	Small molecule	80 mg/m2	Intravenous
Background	Carboplatin	Small molecule	—	—

Indications